New antibiotic to combat deadly bacterial ‘superbugs’ enters clinical trials
2021-06-18
In a critical step towards addressing an urgent unmet medical need due to infections caused by antibiotic-resistant bacteria – also known as ‘superbugs’ – a new antibiotic (QPX9003) discovered by Monash University researchers has entered Phase 1 clinical trials in the United States. The trials have been initiated by theRead More →